The Experts below are selected from a list of 186 Experts worldwide ranked by ideXlab platform

Alexandra M. Oster - One of the best experts on this subject based on the ideXlab platform.

  • hpv Vaccine coverage among men who have sex with men national hiv behavioral surveillance system united states 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Lauri E. Markowitz, Gabriela Pazbailey, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

  • HPV Vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Gabriela Paz-bailey, Lauri E. Markowitz, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

Onofre Muñoz - One of the best experts on this subject based on the ideXlab platform.

  • Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México
    BMC public health, 2010
    Co-Authors: Gonzalo Gutiérrez, Ricardo Pérez-cuevas, Santiago Levy, Hortensia Reyes, Benjamín Acosta, Sonia Fernández Cantón, Onofre Muñoz
    Abstract:

    In 2001, the Instituto Mexicano del Seguro Social (IMSS) carried out a major reorganization to provide comprehensive preventive care to reinforce primary care services through the PREVENIMSS program. This program divides the population into programmatic age groups that receive specific preventive services: children (0-9 years), adolescents (10-19 years), men (20-59 years), women (20-59 years) and older adults (> = 60 years). The objective of this paper is to describe the improvement of the PREVENIMSS program in terms of the increase of coverage of preventive actions and the identification of unmet needs of unsolved and emergent health problems. From 2003 to 2006, four nation-wide cross-sectional probabilistic population based surveys were conducted using a four stage sampling design. Thirty thousand households were visited in each survey. The number of IMSS members interviewed ranged from 79,797 respondents in 2003 to 117,036 respondents in 2006. The four surveys showed a substantial increase in coverage indicators for each age group: children, completed schemes of vaccination (> 90%), iron supplementation (17.8% to 65.5%), newborn screening for metabolic disorders (60.3% to 81.6%). Adolescents, measles - rubella Vaccine (52.4% to 71.4%), Hepatitis Vaccine (9.3% to 46.2%), use of condoms (17.9% to 59.9%). Women, measles-rubella Vaccine (28.5% to 59-2%), cervical cancer screening (66.7% to 75%), breast cancer screening (> 2.1%). Men, type 2 diabetes screening (38.6% to 57.8%) hypertension screening (48-4% to 64.0%). Older adults, pneumococcal Vaccine (13.2% to 24.9%), influenza Vaccine (12.6% to 52.9) Regarding the unmet needs, the prevalence of anemia in children was 30% and a growing prevalence of overweight and obesity, type 2 diabetes, and hypertension was found in men, women and older adults. PREVENIMSS showed an important increase in the coverage of preventive services and stressed the magnitude of the old and new challenges that this healthcare system faces. The unsolved problems such as anemia, and the emerging ones such as overweight, obesity, among others, point out the need to strength preventive care through designing and implementing innovative programs aimed to attain effective coverage for those conditions in which prevention obtains substandard results.

  • Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México
    BMC Public Health, 2010
    Co-Authors: Gonzalo Gutiérrez, Ricardo Pérez-cuevas, Santiago Levy, Hortensia Reyes, Benjamín Acosta, Sonia Fernández Cantón, Onofre Muñoz
    Abstract:

    Background In 2001, the Instituto Mexicano del Seguro Social (IMSS) carried out a major reorganization to provide comprehensive preventive care to reinforce primary care services through the PREVENIMSS program. This program divides the population into programmatic age groups that receive specific preventive services: children (0- 9 years), adolescents ( 10 - 19 years), men (20-59 years), women (20-59 years) and older adults (> = 60 years). The objective of this paper is to describe the improvement of the PREVENIMSS program in terms of the increase of coverage of preventive actions and the identification of unmet needs of unsolved and emergent health problems. Methods From 2003 to 2006, four nation-wide cross-sectional probabilistic population based surveys were conducted using a four stage sampling design. Thirty thousand households were visited in each survey. The number of IMSS members interviewed ranged from 79,797 respondents in 2003 to 117,036 respondents in 2006. Results The four surveys showed a substantial increase in coverage indicators for each age group: children, completed schemes of vaccination (> 90%), iron supplementation (17.8% to 65.5%), newborn screening for metabolic disorders (60.3% to 81.6%). Adolescents, measles - rubella Vaccine (52.4% to 71.4%), Hepatitis Vaccine (9.3% to 46.2%), use of condoms (17.9% to 59.9%). Women, measles-rubella Vaccine (28.5% to 59-2%), cervical cancer screening (66.7% to 75%), breast cancer screening (> 2.1%). Men, type 2 diabetes screening (38.6% to 57.8%) hypertension screening (48-4% to 64.0%). Older adults, pneumococcal Vaccine (13.2% to 24.9%), influenza Vaccine (12.6% to 52.9) Regarding the unmet needs, the prevalence of anemia in children was 30% and a growing prevalence of overweight and obesity, type 2 diabetes, and hypertension was found in men, women and older adults. Conclusion PREVENIMSS showed an important increase in the coverage of preventive services and stressed the magnitude of the old and new challenges that this healthcare system faces. The unsolved problems such as anemia, and the emerging ones such as overweight, obesity, among others, point out the need to strength preventive care through designing and implementing innovative programs aimed to attain effective coverage for those conditions in which prevention obtains substandard results.

Elissa Meites - One of the best experts on this subject based on the ideXlab platform.

  • hpv Vaccine coverage among men who have sex with men national hiv behavioral surveillance system united states 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Lauri E. Markowitz, Gabriela Pazbailey, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

  • HPV Vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Gabriela Paz-bailey, Lauri E. Markowitz, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

Gonzalo Gutiérrez - One of the best experts on this subject based on the ideXlab platform.

  • Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México
    BMC public health, 2010
    Co-Authors: Gonzalo Gutiérrez, Ricardo Pérez-cuevas, Santiago Levy, Hortensia Reyes, Benjamín Acosta, Sonia Fernández Cantón, Onofre Muñoz
    Abstract:

    In 2001, the Instituto Mexicano del Seguro Social (IMSS) carried out a major reorganization to provide comprehensive preventive care to reinforce primary care services through the PREVENIMSS program. This program divides the population into programmatic age groups that receive specific preventive services: children (0-9 years), adolescents (10-19 years), men (20-59 years), women (20-59 years) and older adults (> = 60 years). The objective of this paper is to describe the improvement of the PREVENIMSS program in terms of the increase of coverage of preventive actions and the identification of unmet needs of unsolved and emergent health problems. From 2003 to 2006, four nation-wide cross-sectional probabilistic population based surveys were conducted using a four stage sampling design. Thirty thousand households were visited in each survey. The number of IMSS members interviewed ranged from 79,797 respondents in 2003 to 117,036 respondents in 2006. The four surveys showed a substantial increase in coverage indicators for each age group: children, completed schemes of vaccination (> 90%), iron supplementation (17.8% to 65.5%), newborn screening for metabolic disorders (60.3% to 81.6%). Adolescents, measles - rubella Vaccine (52.4% to 71.4%), Hepatitis Vaccine (9.3% to 46.2%), use of condoms (17.9% to 59.9%). Women, measles-rubella Vaccine (28.5% to 59-2%), cervical cancer screening (66.7% to 75%), breast cancer screening (> 2.1%). Men, type 2 diabetes screening (38.6% to 57.8%) hypertension screening (48-4% to 64.0%). Older adults, pneumococcal Vaccine (13.2% to 24.9%), influenza Vaccine (12.6% to 52.9) Regarding the unmet needs, the prevalence of anemia in children was 30% and a growing prevalence of overweight and obesity, type 2 diabetes, and hypertension was found in men, women and older adults. PREVENIMSS showed an important increase in the coverage of preventive services and stressed the magnitude of the old and new challenges that this healthcare system faces. The unsolved problems such as anemia, and the emerging ones such as overweight, obesity, among others, point out the need to strength preventive care through designing and implementing innovative programs aimed to attain effective coverage for those conditions in which prevention obtains substandard results.

  • Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México
    BMC Public Health, 2010
    Co-Authors: Gonzalo Gutiérrez, Ricardo Pérez-cuevas, Santiago Levy, Hortensia Reyes, Benjamín Acosta, Sonia Fernández Cantón, Onofre Muñoz
    Abstract:

    Background In 2001, the Instituto Mexicano del Seguro Social (IMSS) carried out a major reorganization to provide comprehensive preventive care to reinforce primary care services through the PREVENIMSS program. This program divides the population into programmatic age groups that receive specific preventive services: children (0- 9 years), adolescents ( 10 - 19 years), men (20-59 years), women (20-59 years) and older adults (> = 60 years). The objective of this paper is to describe the improvement of the PREVENIMSS program in terms of the increase of coverage of preventive actions and the identification of unmet needs of unsolved and emergent health problems. Methods From 2003 to 2006, four nation-wide cross-sectional probabilistic population based surveys were conducted using a four stage sampling design. Thirty thousand households were visited in each survey. The number of IMSS members interviewed ranged from 79,797 respondents in 2003 to 117,036 respondents in 2006. Results The four surveys showed a substantial increase in coverage indicators for each age group: children, completed schemes of vaccination (> 90%), iron supplementation (17.8% to 65.5%), newborn screening for metabolic disorders (60.3% to 81.6%). Adolescents, measles - rubella Vaccine (52.4% to 71.4%), Hepatitis Vaccine (9.3% to 46.2%), use of condoms (17.9% to 59.9%). Women, measles-rubella Vaccine (28.5% to 59-2%), cervical cancer screening (66.7% to 75%), breast cancer screening (> 2.1%). Men, type 2 diabetes screening (38.6% to 57.8%) hypertension screening (48-4% to 64.0%). Older adults, pneumococcal Vaccine (13.2% to 24.9%), influenza Vaccine (12.6% to 52.9) Regarding the unmet needs, the prevalence of anemia in children was 30% and a growing prevalence of overweight and obesity, type 2 diabetes, and hypertension was found in men, women and older adults. Conclusion PREVENIMSS showed an important increase in the coverage of preventive services and stressed the magnitude of the old and new challenges that this healthcare system faces. The unsolved problems such as anemia, and the emerging ones such as overweight, obesity, among others, point out the need to strength preventive care through designing and implementing innovative programs aimed to attain effective coverage for those conditions in which prevention obtains substandard results.

Lauri E. Markowitz - One of the best experts on this subject based on the ideXlab platform.

  • hpv Vaccine coverage among men who have sex with men national hiv behavioral surveillance system united states 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Lauri E. Markowitz, Gabriela Pazbailey, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

  • HPV Vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011
    Vaccine, 2014
    Co-Authors: Elissa Meites, Gabriela Paz-bailey, Lauri E. Markowitz, Alexandra M. Oster
    Abstract:

    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV Vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV Vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18–26, 157 (4.9%) reported ≥1 Vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2–4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3–3.3), reported a positive HIV test (aPR 2.2, CI: 1.5–3.2), or received Hepatitis Vaccine (aPR 3.9, CI: 2.4–6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV Vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.